Latest

Latest lung cancer News | Page 5

  • Latest lung cancer news stories and updates. What is happening today? All recent lung cancer news and developments. Live coverage and timeline of lung cancer. All you need to know about lung cancer.
Major gaps in lung cancer services across Australia and New Zealand: study
Filament formation enables cancer cells’ glutamine addiction
Studying Metastases And Drug Resistance In Lung Cancer
Two datopotamab deruxtecan applications validated in the EU for patients with advanced nonsquamous non-small cell lung cancer or HR-positive, HER2-negative breast cancer
Losing weight associated with an increased cancer risk – a closer look at the study
$15,000 grant gives advanced cancer patients a break in Albany
Genetic signature may predict lung cancer response to immunotherapy
Datopotamab deruxtecan Biologics License Application accepted in the US for patients with previously treated advanced nonsquamous non-small cell lung cancer
Tagrisso with the addition of chemotherapy approved in the US for patients with EGFR-mutated advanced lung cancer
Trial increases survival rates for mesothelioma patients
UQ health and medical research secures $10.2 million boost
Improving survival rates for deadly lung diseases
New data shows top five cancers projected to affect people in Nepean Blue Mountains Local Health District
Changes to workplace exposure standard for welding fumes
Combo treatment improves lung cancer outcomes
Netflix’s You Are What You Eat uses a twin study. Here’s why studying twins is so important for science
DSI Underground delegates receive 2023 Yossi Berger Award
QIMR Berghofer engages AI partner to fast-track cancer drug discovery
Cancer Council welcomes ban on engineered stone products, protecting the lungs of thousands of Australian workers
Cheaper medicines for breast cancer, small cell lung cancer, biliary tract cancer, juvenile idiopathic arthritis and Crohn’s disease
Even small amounts of physical activity could be valuable in late-stage lung cancer
New respite care facility coming soon to Queanbeyan
Breathing highway air increases blood pressure, UW research finds 
Asbestos still risk to workers 20 years on from ban
New WHO campaign highlights tobacco industry tactics to influence public health policies
Smoking is the leading cause of chronic obstructive pulmonary disease
Are you silica smart?
How cancer works – decade’s research unlocks secrets
One punch isn’t enough to overcome a common cancer mutation
New centre to develop treatments for aggressive cancers
About 100 people a month are diagnosed with lung cancer in WA
Australia’s tenth annual National Asbestos Awareness Month launches new Asbestos Education resource for residential property owners, managers and tradies to help save lives
Dom’s Finding strength in being open about cancer
Positive efficacy result for Immutep’s ‘efti’ in combination with MSD’s pembrolizumab
Datopotamab deruxtecan improved progression-free survival vs. chemotherapy in patients with previously treated non-small cell lung cancer in TROPION-Lung01 Phase III trial
Enhertu approved in the EU as the first HER2-directed therapy for patients with HER2-mutant advanced non-small cell lung cancer
Construction blitz to target falls from height and asbestos  
Tagrisso plus chemotherapy reduced the risk of disease progression in the brain by 42% in patients with EGFR-mutated advanced lung cancer and…
Important workers compensation reforms supporting fire-fighters pass Parliament
COVID-19 first infectious disease in top 5 causes of death since 1970
New target to beat cancer drug resistance
Progressing nation-leading reforms for our firefighters
Imugene secures new patent in Japan for PD1-Vaxx clinical drug candidate
Enhertu demonstrated strong and durable tumour responses in previously treated HER2-mutant advanced lung cancer in DESTINY-Lung02 Phase II trial
Datopotamab deruxtecan plus Imfinzi showed promising clinical activity in the first-line advanced non-small cell lung cancer setting in TROPION-Lung04 Phase Ib trial
Leading the way in health and safety for Tasmania’s fire-fighters
Action still required to eliminate the harm caused by engineered stone
AstraZeneca data at WCLC advance ambition to have an AstraZeneca medicine for more than half of all patients treated for lung cancer by 2030

© 2026 - The National Tribune Australia